Navigation Links
BMC awarded NIH grant to train Ugandans in basic research on TB
Date:6/16/2014

(Boston)--Boston Medical Center (BMC) was recently awarded a five-year, $861,000 grant from the National Institutes of Health's Fogarty International Center to train Ugandans in basic research involving tuberculosis and emerging infectious diseases at Boston University School of Medicine. The award was funded by Fogarty's Global Infectious Disease (GID) Research Training program, and seeks to build research capacity related to infectious diseases that are endemic in developing countries. BMC was one of five institutions to receive funding to enhance infectious disease research training in low- and middle-income countries.

This grant will help to establish an important capacity-building initiative with Makerere University (MU) in Uganda that offers translational research training on immunology, inflammation, pathogenesis, bioinformatics on tuberculosis, emerging viral pathogens and antimicrobial resistance. The initiative will enable five postdoctoral faculty members from Makerere to obtain masters of art's degree in pathology at Boston University School of Medicine (BUSM) that includes two years of basic research training at the school.

The program will provide rigorous training in basic research approaches and methodology comparable to that of U.S. trainees. Once trained in a scientific discipline, the Ugandan trainee may choose a disease focus (TB or other emerging infectious diseases) or remain basic in orientation (immunology, bioinformatics) depending on their interest and the needs of MU.

"The goal of this program is to develop institutional and national capacity at MU to conduct basic sciences research on emerging infectious diseases and TB," explained Jerrold Ellner, MD, professor of infectious diseases at BUSM and Chief of infectious diseases at BMC and principal investigator of the award. Ellner has studied the immunopathogenesis of TB and TB in HIV patients through prior research collaborations in Uganda.

According to Ellner over the last two decades, MU has evolved into one of the principal academic institutions worldwide for collaborative research on TB and emerging infectious diseases. "Although donors have contributed substantial support for clinical research/training, we address an unmet need: training of future faculty in basic sciences research. The program will advance MU to a full self-sufficient partner and leader in diagnostics, treatments, vaccines and understanding the pathogenesis and correlates of protective immunity," he added.

The principal investigator in Uganda is Mose Joloba, MbChB, PhD, chair of the department of microbiology at MU. The scientific director is Caroline Genco, PhD, a professor of medicine, microbiology and immunology at BUSM.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. JAX cancer researchers awarded NCI provocative questions grants
2. CHORI scientist Dan Granoff awarded prestigious Maurice Hillman/Merck Award
3. Beaumont Childrens Hospital awarded $20,000 from CureSearch for cancer research
4. UTMB awarded $4.4M to develop universal flu vaccine
5. Scientists awarded grant to develop diagnostics for cancer, rheumatoid arthritis, colitis
6. Dartmouth awarded lead role in NCI clinical trials network
7. LSUHSC awarded NSF grant for summer research experience for underrepresented undergrads
8. Scripps Florida scientist awarded $2.3 million to study dengue fever and related viruses
9. LSTM-Eisai-UoL awarded GHIT Fund to deliver anti-Wolbachia drug discovery
10. Kessler Foundation MS scientist awarded Patterson Trust Award in Clinical Research
11. Sloan Research Fellowships awarded to 126 young scholars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... In its efforts of bringing quality senior care ... franchise development and expansion as it welcomes Ferdie Vasquez of the new 1Heart Caregiver ... his 32 years of working in various industries. He had been a Franchise ...
(Date:4/28/2016)... ... 2016 , ... Sublime Beauty® is offering a special deal on its webstore. , Buy 1 ... is applied to the product with lesser value. In addition, a free bonus of ... more in products. , "So many women (men, too) love our products and get good ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ProText Layouts ... Final Cut Pro X . With ProText Layouts, video editors can create ... to match the length and scale of texts. Creating text-based videos have never ...
(Date:4/28/2016)... ... , ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to ... at the University of Montana on April 28-May 1. Varize will compete on Saturday ... order to qualify, Varize needed to place top seven all-around in her respective age ...
(Date:4/28/2016)... ... 2016 , ... The ARRS 2016 Annual Meeting ... from around the globe who attended a week’s worth of cutting-edge scientific presentations, ... included the introduction of the 2016 ARRS Distinguished Educator, Dr. Gerald F. Abbott, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Treato , the ... announced today that it has been named a Cool ... in Life Sciences, 2016, Stephen Davies , ... focuses on life-science- oriented analytics, algorithms and smart machine ... doctors, confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... 28, 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery systems, ... PIONEERS 2016 conference, presented by Joseph Gunnar & ... New York . Nadav Kidron , CEO ... Presentation Details:   PIONEERS 2016, ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
Breaking Medicine Technology: